Not applicableLooking for participantsNCT07452432What this trial is testingKorean Prospective Upper Tract Urothelial Carcinoma CohortWho this might be right forUrothelial Carcinoma (UC) Samsung Medical Center 300
Testing effectiveness (Phase 2)Study completedNCT00066352What this trial is testingBortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or UreterWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter University Health Network, Toronto
Large-scale testing (Phase 3)Ended earlyNCT00042887What this trial is testingChemotherapy With or Without Surgery in Treating Patients With Bladder CancerWho this might be right forBladder Cancer European Organisation for Research and Treatment of Cancer - EORTC 58
Not applicableLooking for participantsNCT03973671What this trial is testingProspective Sample Collection for Cancer of BladderWho this might be right forUrinary Bladder Neoplasms Universitaire Ziekenhuizen KU Leuven 300
Testing effectiveness (Phase 2)Looking for participantsNCT07241793What this trial is testingPhase II Study of Trastuzumab Rezetecan or in Combination With Adebrelimab in HER2-Expressing Locally Advanced or Metastatic Urothelial Carcinoma (la/mUC)Who this might be right forUrothelial CarcinomaAdvanced Urothelial CarcinomaUrothelial Carcinoma Recurrent Sun Yat-sen University 96
Testing effectiveness (Phase 2)Study completedNCT00407485What this trial is testingVEGF Trap in Treating Patients With Recurrent, Locally Advanced, or Metastatic Cancer of the UrotheliumWho this might be right forAdenocarcinoma of the BladderDistal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and Ureter+10 more National Cancer Institute (NCI) 22
Large-scale testing (Phase 3)Active Not RecruitingNCT05243550What this trial is testingSingle-Arm Study of UGN-102 for Treatment of Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder CancerWho this might be right forBladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder UroGen Pharma Ltd. 240
Testing effectiveness (Phase 2)Study completedNCT03558503What this trial is testingA Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder CancerWho this might be right forBladder CancerUrothelial CarcinomaUrothelial Carcinoma Bladder UroGen Pharma Ltd. 63
Not applicableStudy completedNCT02647112What this trial is testingUtility of Bladder EpiCheck for Detection of Recurrent Urothelial CarcinomaWho this might be right forBladder Cancer Nucleix Ltd. 1,050
Large-scale testing (Phase 3)Not Yet RecruitingNCT05810623What this trial is testingSingle-Dose Intravesical Chemotherapy After Diagnostic URSWho this might be right forUpper Urinary Tract Urothelial CarcinomaBladder Cancer David D'Andrea 394
Testing effectiveness (Phase 2)UnknownNCT03209206What this trial is testingThe Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder RecurrenceWho this might be right forUrothelial Carcinoma Seoul National University Hospital 84
Not applicableUnknownNCT02471547What this trial is testingIntravesically Heated Thermo-chemotherapy With Mitomycin-C Prior to TURBTWho this might be right forTransitional Cell Carcinoma Sheba Medical Center 300
Not applicableStudy completedNCT02700464What this trial is testingThe Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell CarcinomaWho this might be right forBladder Cancer Nucleix Ltd. 680
Large-scale testing (Phase 3)Study completedNCT00729287What this trial is testingSelenium in Preventing Cancer Recurrence in Patients With Bladder CancerWho this might be right forBladder Cancer KU Leuven 276
Testing effectiveness (Phase 2)Looking for participantsNCT06770582What this trial is testingTesting the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC TrialWho this might be right forNon-Muscle Invasive Bladder Urothelial CarcinomaRecurrent Non-Muscle Invasive Bladder Urothelial CarcinomaStage I Bladder Cancer AJCC v8 National Cancer Institute (NCI) 160
Testing effectiveness (Phase 2)Study completedNCT00478361What this trial is testingGemcitabine, Paclitaxel, Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney FunctionWho this might be right forDistal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterProximal Urethral Cancer+8 more M.D. Anderson Cancer Center 40
Large-scale testing (Phase 3)UnknownNCT00003725What this trial is testingSurgery With or Without Chemotherapy in Treating Patients With Newly Diagnosed or Recurrent Bladder CancerWho this might be right forBladder Cancer Anthra Pharmaceuticals 300
Testing effectiveness (Phase 2)Ended earlyNCT00004856What this trial is testingTrastuzumab in Treating Patients With Previously Treated, Locally Advanced, or Metastatic Cancer of the UrotheliumWho this might be right forDistal Urethral CancerMetastatic Transitional Cell Cancer of the Renal Pelvis and UreterProximal Urethral Cancer+6 more National Cancer Institute (NCI) 40
Early research (Phase 1)Ended earlyNCT00072137What this trial is testingNeoadjuvant Intravesical Vaccine Therapy in Treating Patients With Bladder Carcinoma Who Are Undergoing CystectomyWho this might be right forBladder AdenocarcinomaBladder Squamous Cell CarcinomaBladder Urothelial Carcinoma+5 more National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Study completedNCT00003105What this trial is testingCombination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder CancerWho this might be right forBladder CancerTransitional Cell Cancer of the Renal Pelvis and Ureter Memorial Sloan Kettering Cancer Center 30